According to Benzinga Pro, Baidu's peer group average for short interest as a percentage of float is 8.93%, which means the ...

For a company long defined by proprietary development, this move is a symbol of a broader technological undercurrent sweeping ...

The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals' Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 ...

US stocks finished firmly in the red on Monday as traders returned to their desks after a long weekend in a risk-off mood, ...

The Dow opened 132.29 points lower on Monday, taking a bite out of gains registered in Thursday's truncated session, which ...

33 analysts are following Baidu and have set target prices ranging from $76.145195 to $159.21521 per share. On average, they have given the company a rating of buy. At today's prices, BIDU is trading ...